Empiric tuberculosis treatment in retreatment patients in high HIV/tuberculosis-burden settings

Lancet Infect Dis. 2014 Sep;14(9):795-6. doi: 10.1016/S1473-3099(14)70881-3.

Authors

Manica Balasegaram¹, Grania Brigden²

Affiliations

¹ Access Campaign, Médecins Sans Frontières, 78 Rue de Lausanne, Geneva, Switzerland.
² Access Campaign, Médecins Sans Frontières, 78 Rue de Lausanne, Geneva, Switzerland. Electronic address: grania.brigden@geneva.msf.org.

PMID: 25164192
DOI: 10.1016/S1473-3099(14)70881-3

No abstract available

Publication types

Letter
Comment

MeSH terms

Antitubercular Agents / therapeutic use*
Clinical Trials as Topic*
Drug Discovery*
Humans
Tuberculosis, Multidrug-Resistant / drug therapy*
Tuberculosis, Pulmonary / drug therapy*

Substances

Antitubercular Agents